Axogen Inc [AXGN] stock is trading at $13.9, down -1.21%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AXGN shares have gain 9.71% over the last week, with a monthly amount glided 15.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Axogen Inc [NASDAQ: AXGN] stock has seen the most recent analyst activity on March 17, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $30. Previously, Raymond James started tracking the stock with Outperform rating on July 01, 2024, and set its price target to $13. Canaccord Genuity upgraded its rating to a Buy and increased its price target to $15 on May 09, 2022. Guggenheim started tracking with a Buy rating for this stock on October 23, 2020, and assigned it a price target of $24.
Axogen Inc [AXGN] stock has fluctuated between $9.22 and $21.00 over the past year. Axogen Inc [NASDAQ: AXGN] shares were valued at $13.9 at the most recent close of the market.
Analyzing the AXGN fundamentals
Axogen Inc [NASDAQ:AXGN] reported sales of 203.27M for the trailing twelve months, which represents a growth of 18.26%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.04 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.61.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Axogen Inc’s Current Ratio is 4.14. In addition, the Quick Ratio stands at 2.67 and the Cash Ratio stands at 1.04. Considering the valuation of this stock, the price to sales ratio is 3.15, the price to book ratio is 5.67.
Transactions by insiders
Recent insider trading involved Weiler Kathy Johnson, Director, that happened on Jun 09 ’25 when 4073.0 shares were sold. Director, Levine Alan M completed a deal on Jun 09 ’25 to sell 4073.0 shares. Meanwhile, Director Wendell Amy McBride sold 4073.0 shares on Jun 09 ’25.
